CD44: a cancer stem cell marker and therapeutic target in leukemia treatment

被引：10
|
作者：
Wu, Shuang [1 ,2 ]
Tan, Yicheng [1 ,2 ,3 ]
Li, Fanfan [2 ,3 ,4 ]
Han, Yixiang [2 ,3 ,5 ]
Zhang, Shenghui [1 ,2 ,3 ,4 ]
Lin, Xiaofei [4 ]
机构：
[1] Wenzhou Med Univ, Lab Anim Ctr, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Inst Hematol, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Key Lab Hematol, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[5] Wenzhou Med Univ, Cent Lab, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金：
中国国家自然科学基金;
关键词：
CD44; leukemia; adhesion; migration; homing; differentiation; biomarkers; clinical application; ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; HYALURONAN-CD44; INTERACTION; ADHESION MOLECULES; SOLUBLE CD44; BONE-MARROW; POOR-PROGNOSIS; ERM PROTEINS; SERUM CD44; EXPRESSION;
D O I：
10.3389/fimmu.2024.1354992
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CD44 is a ubiquitous leukocyte adhesion molecule involved in cell-cell interaction, cell adhesion, migration, homing and differentiation. CD44 can mediate the interaction between leukemic stem cells and the surrounding extracellular matrix, thereby inducing a cascade of signaling pathways to regulate their various behaviors. In this review, we focus on the impact of CD44s/CD44v as biomarkers in leukemia development and discuss the current research and prospects for CD44-related interventions in clinical application.
引用
收藏
页数：16
相关论文
共 50 条
  • [11] Role of CD44 as a marker of cancer stem cells in head and neck cancer
    Trapasso, Serena
    Allegra, Eugenia
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 379 - 383
  • [12] CD44 as a stem cell marker in head and neck squamous cell carcinoma
    Faber, Anne
    Barth, Christine
    Hoermann, Karl
    Kassner, Stefan
    Schultz, Johannes David
    Sommer, Ulrich
    Stern-Straeter, Jens
    Thorn, Carsten
    Goessler, Ulrich Reinhart
    ONCOLOGY REPORTS, 2011, 26 (02) : 321 - 326
  • [13] Cd44 As A Possible Functional Marker For Lung Cancer Stem Cells
    Nishino, M.
    Hegab, A. E.
    Arai, D.
    Kuroda, A.
    Soejima, K.
    Saya, H.
    Betsuyaku, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [14] CD44 Glycosylation as a Therapeutic Target in Oncology
    Liao, Chengcheng
    Wang, Qian
    An, Jiaxing
    Chen, Jie
    Li, Xiaolan
    Long, Qian
    Xiao, Linlin
    Guan, Xiaoyan
    Liu, Jianguo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [15] CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer
    Shen, Chenling
    Xiang, Mingliang
    Nie, Chen
    Hu, Haixia
    Ma, Yan
    Wu, Hao
    ACTA OTO-LARYNGOLOGICA, 2013, 133 (11) : 1219 - 1226
  • [16] The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
    Jiaying Lin
    Ding Ding
    Cancer Cell International, 17
  • [17] The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
    Lin, Jiaying
    Ding, Ding
    CANCER CELL INTERNATIONAL, 2017, 17
  • [18] Prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis
    Shi, Y. Y.
    Jiang, H.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (03)
  • [19] Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/ plus ) mice attenuates intestinal tumorigenesis
    Zeilstra, Jurrit
    Joosten, Sander P. J.
    Dokter, Maarten
    Verwiel, Eugene
    Spaargaren, Marcel
    Pals, Steven T.
    CANCER RESEARCH, 2008, 68 (10) : 3655 - 3661
  • [20] In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker
    Ababneh, Nidaa
    Alshaer, Walhan
    Allozi, Omar
    Mahafzah, Azmi
    El-Khateeb, Mohammed
    Hillaireau, Herve
    Noiray, Magali
    Fattal, Elias
    Ismail, Said
    NUCLEIC ACID THERAPEUTICS, 2013, 23 (06) : 401 - 407
12345